Conagra Brands (CAG) Financials

Conagra Brands (NYSE: CAG) has shown a generally positive revenue and cash-flow trajectory over the last four years, but faces a meaningful one-time impairment and ongoing debt considerations that weigh on earnings and financing activity. Below are the 10 most material takeaways for retail investors, separated into positives, neutral observations, and negatives.

• Revenue trend: Operating revenue has trended up toward the $3.0 billion level, with 2026 Q2 revenue at about $2.98 billion, up from the mid-$2.7–$2.8 billion range in 2024–2025.
• Gross margin stability: Gross margin has hovered in the mid-20s percent (roughly 23–26%) across recent quarters, indicating consistent product-line profitability despite revenue swings.
• Strengthening operating cash flow: Net cash from continuing operating activities has been solid, with notable peaks (e.g., about $676.7 million in 2025 Q3) and sustained positive cash generation in 2024–2025.
• Free cash flow generation in several quarters: Examples include roughly $503 million in 2025 Q3, about $260 million in 2025 Q4, and around $138 million in 2026 Q2, illustrating meaningful cash left after capital spending in multiple periods.
• Dividend stability: Cash dividends per share are consistently set at $0.35, providing ongoing income to shareholders.
• Solid balance-sheet base: Total assets run in the high-teens to low-twenties of billions, with total equity around $8.8–9.2 billion in 2024–2026, and cash balances that are modest relative to total assets—indicative of reliance on operating cash flow for liquidity.
• Working-capital dynamics: Inventory, accounts receivable, and accounts payable generally track revenue growth, suggesting normal working-capital needs rather than extreme stress in most quarters.
• Profitability variability: Net income has been positive in many quarters, but the company has shown volatility, including a few material weaker quarters (e.g., early 2023 and 2026 Q2), reflecting earnings sensitivity to external factors.
• Impairment-related earnings drag: A substantial impairment charge in 2026 Q2 of 968.3 million dollars significantly reduced operating income and contributed to a negative quarterly result.
• Debt and financing pressure: Net financing activity has often been negative in several quarters (significant outflows in multiple periods), and long-term debt remains sizable (on the order of $6–7 billion), which adds financing costs and balance-sheet pressure.